Targeting the K-Ras - JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formationMasashi Okada, Chifumi Kitanaka|Oncotarget|2014Cited by 74
The novel JNK inhibitor AS602801 inhibits cancer stem cells <i>in vitro</i> and <i>in vivo</i>Masashi Okada, Chifumi Kitanaka|Oncotarget|2016Cited by 59
JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expressionMasashi Okada, Chifumi Kitanaka|International Journal of Oncology|2013Cited by 54
Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin ReductionShuhei Suzuki, Masashi Okada|Cancers|2019Cited by 42
Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunctionKenta Kuramoto, Masashi Okada|FEBS Open Bio|2017Cited by 38